These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 3900812

  • 21. Knowledge, attitudes, and reported practices among obstetrician-gynecologists in the USA regarding antibiotic prescribing for upper respiratory tract infections.
    Chamany S, Schulkin J, Rose CE, Riley LE, Besser RE.
    Infect Dis Obstet Gynecol; 2005 Mar; 13(1):17-24. PubMed ID: 16040323
    [Abstract] [Full Text] [Related]

  • 22. [Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage].
    Cazzola M, Noschese P, Vinciguerra A, Di Perna F, Califano C, Berra A.
    Minerva Med; 1998 Mar; 89(1-2):15-22. PubMed ID: 9561021
    [Abstract] [Full Text] [Related]

  • 23. A standardized regimen of antibiotics prevents infectious complications in skull base surgery.
    Kraus DH, Gonen M, Mener D, Brown AE, Bilsky MH, Shah JP.
    Laryngoscope; 2005 Aug; 115(8):1347-57. PubMed ID: 16094103
    [Abstract] [Full Text] [Related]

  • 24. [Ceftazidime in the treatment of severe bacterial infections].
    Maresová V, Cizmárová L, Havlík J, Stafová J, Vacek V, Gabrielová A, Neubertová K.
    Sb Lek; 1988 Nov; 90(11-12):339-43. PubMed ID: 3064274
    [No Abstract] [Full Text] [Related]

  • 25. Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
    Rains CP, Bryson HM, Peters DH.
    Drugs; 1995 Apr; 49(4):577-617. PubMed ID: 7789291
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Antibiotic selection for infections in obstetric patients.
    Duff P.
    Semin Perinatol; 1993 Dec; 17(6):367-78. PubMed ID: 8160020
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Rifampicin in the treatment of infections of non-tuberculous etiology].
    Lobuseva AN, Pozdniakova VP, Umnova LV, Fomina IP, Bogomolova NS.
    Antibiot Khimioter; 1988 Dec; 33(12):926-9. PubMed ID: 3245710
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Ceftazidime: a new cephalosporin of broad spectrum].
    Gandulla LM.
    Medicina (B Aires); 1986 Dec; 46(3):341-51. PubMed ID: 3553840
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Anaerobic infections I. Subject in a meeting at the Institute of Pharmacotherapy, March, 1975].
    Schreiner A, Solberg CO.
    Tidsskr Nor Laegeforen; 1976 Feb 10; 96(4):249-52. PubMed ID: 1251400
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clinical experience with ceftazidime in the management of a variety of gram-negative infections.
    Spantideas A.
    Chemioterapia; 1987 Jun 10; 6(2 Suppl):377-8. PubMed ID: 3334580
    [No Abstract] [Full Text] [Related]

  • 39. Ceftazidime: a new broad spectrum cephalosporin.
    Moellering RC.
    Pediatr Infect Dis; 1985 Jun 10; 4(4):390-3. PubMed ID: 3895178
    [No Abstract] [Full Text] [Related]

  • 40. Studies on a new formulation of ceftazidime--ceftazidime arginine--in patients with recurrent chest infections.
    Davies BI, Maesen FP, Baur C, Evers WB.
    J Antimicrob Chemother; 1987 Jul 10; 20(1):133-6. PubMed ID: 3305461
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.